Next Article in Journal
Associations between Religiosity, Spirituality, and Happiness among Adults Living with Neurological Illness
Next Article in Special Issue
Advance Care Planning for Older People with Cancer and Its Implications in Asia: Highlighting the Mental Capacity and Relational Autonomy
Previous Article in Journal
Prediction of Emergency Department Re-Visits in Older Patients by the Identification of Senior at Risk (ISAR) Screening
Previous Article in Special Issue
“Sacred Work”: Reflections on the Professional and Personal Impact of an Interdisciplinary Palliative Oncology Clinical Experience by Social Work Learners
Communication

Optimising Clinical Trial Design in Older Cancer Patients

Discipline of Radiation Therapy, School of Medicine, Trinity College Dublin, Dublin, Ireland
*
Author to whom correspondence should be addressed.
Geriatrics 2018, 3(3), 34; https://doi.org/10.3390/geriatrics3030034
Received: 30 May 2018 / Revised: 13 June 2018 / Accepted: 21 June 2018 / Published: 22 June 2018
(This article belongs to the Special Issue Oncology Care and Research in the Elderly)
Cancer is predominantly a disease of older patients, with over half of those aged over 65 years of age being diagnosed with cancer at some stage. Despite comprising a significant proportion of the patients that we see in clinical practice, there is a lack of representation of older patients in cancer clinical trials. This is mainly due to restrictive trial inclusion criteria that prevent older patients from participating. Also, trial endpoints, such as overall survival, may not represent the most important and most meaningful endpoints for older patients. The latter may place more significance on quality of life and other outcomes such as functional independence. Baseline assessment using Comprehensive Geriatric Assessment, may provide a better framework for quantifying patient outcomes for varying degrees of fitness or frailty. This short communication makes the case for more age appropriate endpoints, such as quality of life, toxicity and functional independence, and that novel trial designs are necessary to inform evidence-based care of older cancer patients. View Full-Text
Keywords: oncology; clinical trials; geriatric oncology; design; endpoints; quality of life oncology; clinical trials; geriatric oncology; design; endpoints; quality of life
MDPI and ACS Style

Whelehan, S.; Lynch, O.; Treacy, N.; Gleeson, C.; Oates, A.; O’Donovan, A. Optimising Clinical Trial Design in Older Cancer Patients. Geriatrics 2018, 3, 34. https://doi.org/10.3390/geriatrics3030034

AMA Style

Whelehan S, Lynch O, Treacy N, Gleeson C, Oates A, O’Donovan A. Optimising Clinical Trial Design in Older Cancer Patients. Geriatrics. 2018; 3(3):34. https://doi.org/10.3390/geriatrics3030034

Chicago/Turabian Style

Whelehan, Shóna, Orlaith Lynch, Niall Treacy, Ciara Gleeson, Andrea Oates, and Anita O’Donovan. 2018. "Optimising Clinical Trial Design in Older Cancer Patients" Geriatrics 3, no. 3: 34. https://doi.org/10.3390/geriatrics3030034

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop